|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/444 | |
| A61K 31/506 | |||
| A61K 31/55 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Number of the document | 3442529 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17717990.0 |
| Date of filing the European patent application | 2017-04-05 | |
| (97) | Date of publication of the European application | 2019-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/026134 |
| Date | 2017-04-05 |
| (87) | Number | WO 2017/180389 |
| Date | 2017-10-19 |
| (30) | Number | Date | Country code |
| 201662321311 P | 2016-04-12 | US |
| (72) |
BECKMANN, Richard Paul, US
PATEL, Bharvin Kumar, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | COMBINATION THERAPY WITH NOTCH AND CDK4/6 INHIBITORS FOR THE TREATMENT OF LUNG CANCER |
| COMBINATION THERAPY WITH NOTCH AND CDK4/6 INHIBITORS FOR THE TREATMENT OF LUNG CANCER |